HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sakuragi, T. Search for Related Content PubMed Articles by Sakuragi, T. Related Collections Mediastinum

Eur J Cardiothorac Surg 2003;23:254-255
© 2003 Elsevier Science NL

Letter to the Editor

Reply to Spaggiari et al.

Department of Thoracic and Cardiovascular Surgery, Saga Medical School, 5-1-1 Nabeshima, Saga City 849-8501, Japan

Received 18 October 2002; accepted 21 October 2002.

* Tel.: +81-952-342345; fax: +81-952-342061
e-mail: sakurat@post.saga-med.ac.jp

Key Words: Mediastinal carcinoid tumor • Thymic tumor • Neuroendocrine thymic tumor • Chemotherapy

The first 20% of the full text of this article appears below.

The author would like to thank Spaggiari and coworkers for their comments regarding their experience with induction chemotherapy for this rare disease. Indeed, there is very little evidence of the strategy in the worldwide literature. I strongly support their opinions regarding treatment of this tumor.

We have a positive impression of chemotherapy and radiotherapy in the control of this tumor. . . . [Full Text of this Article]